Selective cytotoxicity of a novel mitochondrial complex I inhibitor, YK-135, against EMT-subtype gastric cancer cell lines due to impaired glycolytic capacity

논문상세정보
' Selective cytotoxicity of a novel mitochondrial complex I inhibitor, YK-135, against EMT-subtype gastric cancer cell lines due to impaired glycolytic capacity' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Gastric cancer
  • Glycolytic capacity
  • OXPHOS
  • emt
  • mitochondrial complex i
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
257 0

0.0%

' Selective cytotoxicity of a novel mitochondrial complex I inhibitor, YK-135, against EMT-subtype gastric cancer cell lines due to impaired glycolytic capacity' 의 참고문헌

  • Tumor mutation burden correlates with efficacy of chemotherapy/targeted therapy in advanced non-small cell lung cancer
    Lin C [2020]
  • The promises and challenges of tumor mutation burden as an immunotherapy biomarker : a perspective from the international association for the study of lung cancer pathology committee
    Sholl LM [2020]
  • The natural compound gracillin exerts potent antitumor activity by targeting mitochondrial complex II
    Min HY [2019]
  • The interplay between slow-cycling, chemoresistant cancer cells and fibroblasts creates a proinflammatory niche for tumor progression
    Cho J [2020]
  • Selective cytotoxicity of the NAMPT inhibitor FK866 toward gastric cancer cells with markers of the epithelial-mesenchymal transition, due to loss of NAPRT
    Lee J [2018]
  • Predictive test for chemotherapy response in resectable gastric cancer : a multi-cohort, retrospective analysis
    Cheong JH [2018]
  • Phenformininduced mitochondrial dysfunction sensitizes hepatocellular carcinoma for dual inhibition of mTOR
    Veiga SR [2018]
  • Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes .
  • Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition
    Maharjan S [2014]
  • Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
    Wheaton WW [2014]
  • Metformin directly acts on mitochondria to alter cellular bioenergetics
  • Metabolic rewiring in response to biguanides is mediated by mROS/HIF-1a in malignant lymphocytes
    Khan H [2019]
  • Lacticacidosis, ketoacidosis, and hyperalaninaemia in a phenformintreated diabetic patient
    Ball S [1974]
  • Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Sung H [2021]
  • Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
    Shi Y [2019]
  • Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
    Bridges HR [2014]
  • Comprehensive molecular characterization of gastric adenocarcinoma
  • An inhibitor of oxidative phosphorylation exploits cancer vulnerability
    Molina JR [2018]
  • Adaptation of energy metabolism in breast cancer brain metastases
    Chen EI [2007]
  • AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer
    Motoshima H [2006]
  • AMPK : a target for drugs and natural products with effects on both diabetes and cancer
    Hardie DG [2013]